Jennison Associates’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,295
Closed -$2.93M 752
2015
Q3
$2.93M Buy
3,295
+20
+0.6% +$18.2K ﹤0.01% 575
2015
Q2
$3.37M Buy
+3,275
New +$3.84M ﹤0.01% 577
2014
Q2
Sell
-4,249
Closed -$6.91M 770
2014
Q1
$6.91M Buy
4,249
+11
+0.3% +$23K 0.01% 504
2013
Q4
$5.47M Buy
4,238
+13
+0.3% +$20.8K 0.01% 504
2013
Q3
$8.49M Buy
+4,225
New +$7.85M 0.01% 485

Other funds holding HSTO

Jennison Associates's HSTO Position: Q4 2015 in Review

Jennison Associates sold out of Histogen Inc. Common Stock (HSTO) in Q4 2015, closing a stake of 3,295 shares — an estimated $2.93M sold.

Jennison Associates first reported a position in HSTO in Q3 2013 and held it in 5 quarters. The position peaked at $8.49M in Q3 2013. 43 funds tracked by Wall St. Rank hold HSTO as of Q4 2015.

  • Jennison Associates reported no remaining Histogen Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 3,295 Histogen Inc. Common Stock shares in Q4 2015, an estimated $2.93M.
  • Jennison Associates first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 5 quarters.
  • Jennison Associates's Histogen Inc. Common Stock position peaked at $8.49M in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.